Delivery Order SPE2DB22D1103-SPE2DB24FTNK9

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $10,260.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ADVAIR HFA 115-21 MCG INHALER 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,817.84 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary mechanism for Amerisourcebergen to deliver a range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a $3,267.12 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp's Corporate Office Division to provide ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of May 30, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,410.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ADVAIR HFA 230-21 MCG INHALER 12GM. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp as the prime contractor. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $7,422.21 for the supply of 4564571326 ADVAIR HFA 230-21 MCG INHALER 12GM. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $29,100.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,325.24 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $2,012.09 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of May 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. The IDC enables DLA...
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract worth $12,949.35 to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,564,857,521 units of the ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical product. This is a firm fixed-price contract with a completion date of June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is leveraging its extensive supply chain capabilities to fulfill this order for the DLA, which supports the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $16,844.93 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceuticals. This delivery order was issued under an existing indefinite delivery contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTNK9
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,699.21 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/10/24, 9:11 AM